Other Issues

Browse Other Issues Content

CHPA opposes mandatory manufacturer-funded drug take-back programs as they threaten the affordability of OTC medications that consumers rely on as the first line of defense against common ailments.

Learn about rules and regulations for structured product labeling of OTC medicines.

CHPA encourages state and local lawmakers to refrain from creating new legislation addressing green chemistry in pharmaceuticals, and instead rely on the rigorous guidelines and standards already implemented at the federal level by agencies like the FDA.

The Dietary Supplements Access Act of 2023 is bipartisan legislation intended to give American consumers increased flexibility to best determine how to use their pre-tax dollars to stay healthy.

Though rising PFAS levels prompt important health questions that must be monitored, restrictions should remain grounded in conclusive toxicology to avoid reactionary bans on safe modern alternatives — as inconsistent standards across 50 individual states would only stifle healthcare advancement.

Policymakers should encourage – and empower – individuals to take responsibility for their oral health by supporting daily oral health self-care policies that make beneficial oral care products more accessible.

If you have a flexible spending arrangement (FSA) or health savings account (HSA) you can now use these pre-tax savings for purchasing over-the-counter medicines.

Since the Final Rule was published in 1995, FDA has received six Citizen Petitions (CPs) requesting the addition of alternatives to the animal caries test to the Anticaries Monograph.

Filter Results